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Abstract 
BACKGROUND: Pain is a major postoperative complication worldwide, which in turn impairs normal body 
performance and increases postoperative morbidity, hospitalisation, and the susceptibility to infections which also 
lead to chronic pain development. 
AIM: The purpose of this study was to evaluate the efficacy of intravenous ketorolac versus nalbuphine as 
analgesia after adenotonsillectomy surgery to determine the optimal procedure for pain control and postoperative 
reduction of analgesic use. 
METHODS: A group of 100 pediatric patients undergoing tonsillectomy or adenotonsillectomy were assigned as 
follows to two equal groups: Group A: 50 patients received intravenous ketorolac 0.9 mg/Kg. Group B: 50 patients 
received intravenous nalbuphine 0.25 mg/Kg. 
RESULTS: FLACC (Face, Legs, Activity, Cry, Consolability) pain score was measured after recovery from 
anaesthesia (postoperative). There was a statistically significant difference concerning pain score between group 
‘A’ and group ‘B’ as pain score in 'A' (ranging from 3.18 ± 0.87 to 4.68 ± 0.74) is lower compared to 'B' (ranging 
from 3.90 ± 0.76 to 5.54 ± 0.73) and probability value < 0.05 except at 90 & 120 min which was observed 
statistically insignificant. There was no serious postoperative complication detected in either group. 
CONCLUSION: It is concluded that intravenous ketorolac is more effective than intravenous nalbuphine in 
reducing pain intensity and postoperative analgesic requirements after adenotonsillectomy in children. 
 
 
 
 
 
 
 
 
Introduction 
 
Adenotonsillectomy is one of the most 
frequent ENT surgeries performed in children. 
Postoperative pain can influence the ability of the child 
to tolerate medication for oral pain and fluid intake, 
resulting in nausea and dehydration in a considerable 
number of children postoperatively [1], [2]. 
The operation involves pain in more than 80 
per cent of children on the first day of surgery. It is 
assumed that pain is not treated adequately in half of 
all surgical procedures [3]. 
Although opioids are widely used in 
postoperative pain management, their side effects, 
especially respiratory depression, bradycardia, nausea 
and vomiting, have reduced the use of these 
analgesics, especially in children. Non-steroidal anti-
inflammatory drugs (NSAIDs) have been widely used 
with very good results in pain reduction and 
postoperative opioid requirements after 
adenotonsillectomy in children and adults [4], [5], [6], 
[7], [8]. 
Nalbuphine is an opioid agonist-antagonist 
of the phenanthrene series which was synthesised 
in an attempt to provide analgesia without the 
undesirable side effects of the pure agonists. Its 
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analgesic and possibly certain anti-pruritic effects 
are mediated via actions on the μ and κ-receptors, 
and nalbuphine has been indicated for mild to 
moderate pain [9]. 
NSAIDs act on prostaglandin synthesis for 
pain reduction with adverse effects such as bleeding 
problems in both gastrointestinal tracts and from the 
surgical site and potential renal dysfunction that have 
caused some concerns in their widespread application 
[5], [6], [8], [10]. 
Ketorolac is a non-steroidal anti-inflammatory 
drug (NSAID) that has an analgesic efficacy similar to 
commonly used opioids, and that recently has found 
wide acceptance in the treatment of postoperative 
pain in a variety of surgical procedures. Ketorolac is 
used for moderate pain relief; it may be used to treat 
severe pain when associated with opioids, reducing 
the opioid dose. The advantage of this association is 
the reduction of opioid side effects such as respiratory 
depression, pruritus, urinary retention, sedation and 
nausea [11], [12], [13]. 
This study aimed to evaluate the efficacy of 
intravenous ketorolac versus nalbuphine as analgesia 
after adenotonsillectomy surgery to determine the 
optimal procedure for pain control and postoperative 
reduction of analgesic use. 
 
 
Patients and Methods 
 
This is a prospective randomised clinical 
study designed to assess the effect of intravenous 
ketorolac versus intravenous nalbuphine on 
postoperative pain after tonsillectomy in children. 
The study was carried out in Children Hospital 
of Cairo University (Abu El Reish) on 100 pediatric 
patients following the approval of the Ethical 
committee and obtaining informed consent from 
parents.  
Inclusion criteria: 
- ASA physical status I & II. 
- Age between 2 years & 10 years old. 
- Body weight below 30 Kg. 
Exclusion criteria: 
- ASA physical status ≥ III. 
- Age below 2 years & above 10 years old. 
- Body weight above 30 Kg. 
- Any contraindications to any drug used. 
 
 
Methodology in details 
One hundred patients meeting the inclusion 
criteria were randomly assigned into two equal 
groups: 
Group A: 50 patients received intravenous 
ketorolac 0.9 mg/Kg. 
Group B: 50 patients received intravenous 
nalbuphine 0.25 mg/Kg. 
The investigators did not know the details of 
the series and the group assignment was kept in the 
assets of sealed envelopes with only the case number 
on the outside. 
 
Anesthetic Management 
All patients were visited preoperatively on the 
day before surgery. The entire procedure has been 
explained to the patient, and informed consent has 
been taken. Full history has been taken including 
diseases, bleeding, drug intake, allergy or drug 
sensitivity and previous anaesthetic experience. 
Complete general examination including airway 
evaluation, chest and cardiac auscultation was 
conducted. All patients fasted for an appropriate 
period (6 hours for food, 4 hours for water). 
Laboratory evaluation: complete blood count (CBC), 
prothrombin time and concentration (PT&PC), INR, 
liver function tests, renal function tests. Upon arrival at 
the operating theatre, IV access was established by 
22 G cannula insertion. 
Five lead ECG pulse oximeter and non-
invasive ABP were monitored. Premedication 
injection: atropine sulfate intravenously 0.01 mg/kg 
and dexamethasone intravenously 0.2 mg/kg. 
Induction of anaesthesia by inhalation sevoflurane 
and oral endotracheal intubation of appropriate size 
was done. After induction of anaesthesia, children 
were randomly allocated to receive 0.9 mg/Kg 
ketorolac or 0.25 mg/Kg nalbuphine administered as 
an intravenous injection. Anaesthesia was maintained 
by isoflurane inhalation. IV fluids according to body 
weight “Hartmann's solution”, 1
st
 10 kg 4 ml/kg, 2
nd
 10 
kg 2 ml/kg and for each kg above 20 kg 1 ml/kg fluids. 
 
Data collected 
1-patients characteristics and demographic 
data were collected; age, gender, weight. 
2-Postoperative pain, using “FLACC score 
“(face, legs, activity, cry,consolability ) this scale 
(Table 1) is scored between a range of 0-10 with zero 
representing no pain. The scale has 5 criteria each 
assigned a score of 0, 1, 2. Pain was recorded at 15, 
30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes 
postoperatively. Postoperatively intramuscular 
ketoprofen (1 mg/kg) was used as ‘‘rescue analgesia” 
if pain score > 5. 
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Table: 1 FLACC pain score [14] 
Criteria Score 0 Score 1 Score 2 
Face No particular expression or 
smile 
Occasional grimace or frown, 
withdrawn, uninterested 
Frequent to constant 
quivering chin, clenched 
jaw 
Legs Normal position or relaxed Uneasy, restless, tense Kicking or legs were drawn 
up 
Activity Lying quietly, normal position 
moves easily 
Squirming, shifting, back and forth, 
tense 
Arched, rigid or jerking 
Cry No cry (awake or asleep) Moans or whimpers; occasional 
complaint 
Crying steadily, screams or 
sobs, frequent complaints 
Consola
bility 
Content, relaxed Reassured by occasional touching, 
hugging or being talked to, 
distractible 
Difficult to console or 
comfort 
 
3-Postoperative sedation, using Ramsay 
sedation score (Table 2). 
Table 2: Ramsay sedation score [15] 
Score Observation 
1 Anxious, agitated or restless. 
2 Cooperative, oriented and tranquil 
3 Responsive to commands. 
4 Asleep, but with brisk response to a light glabellar tap or loud auditory 
stimulus. 
5 Asleep, sluggish response to a glabellar tap or auditory Stimulus. 
6 Asleep, no response. 
 
4-Postoperative vomiting occurrence. 
5-Postoperative side effects: respiratory 
depression, oedema, rash or itching were also 
assessed. 
 
Statistical analysis 
Data were statistically described, when 
appropriate, in terms of mean ± standard deviation (± 
SD), frequencies (number of cases) and relative 
frequencies (percentages). The student t-test was 
used to compare quantitative variables among the 
study groups. For comparing categorical data, Chi-
square (2) test was performed. When the expected 
frequency is less than 5, an exact test was used 
instead. A probability value (p-value) less than 0.05 
was considered statistically significant. All statistical 
calculations were done using computer programs 
Microsoft Excel 2010 (Microsoft Corporation, NY, and 
USA) and SPSS (Statistical Package for the Social 
Science; SPSS Inc., Chicago, IL, USA) version 21 for 
Microsoft Windows. 
 
 
Results 
 
One hundred (100) patients were included in 
this study and randomly allocated into 2 groups: group 
A (ketorolac) and group B (nalbuphine). 
Table 3: Demographic data (age & weight) 
Demographic data/Groups A B 
Age 5.18 ± 1.17 5.04 ± 1.26 
Weight 17.06 ± 4.2 16.28 ± 4.63 
Data expressed as mean ± (SD); P value > 0.05. 
 
ASA status is the same in all patients of both 
groups “ASA 1”. 
There was no statistical difference in age, 
weight, and sex between the groups (Table 3 and 4). 
Table 4: Demographic data (sex) 
Sex/Groups A B 
Male 39/50 36/50 
Female 11/50 14/50 
Data expressed as count.; P value > 0.05. 
 
FLACC pain score was measured after 
recovery from anaesthesia (postoperative). There was 
a statistically significant difference concerning pain 
score between group ‘A’ and group ‘B’ as pain score 
in 'A' (ranging from 3.18 ± 0.87 to 4.68 ± 0.74) is lower 
compared to 'B' (ranging from 3.90 ± 0.76 to 5.54 ± 
0.73) and P-value < 0.05 except at 90 & 120 min 
which was observed statistically insignificant (Table 5) 
(Figure 1). 
Table 5: FLACC score at (6 hours) postoperatively 
 Group A Group B 
15 min 3.18 ± 0.87 3.96 ± 0.83* 
30 min 3.36 ± 0.80 3.90 ± 0.76* 
45 min 3.40 ± 0.67 4.34 ± 0.48* 
60 min 3.48 ± 0.65 4.34 ± 0.48* 
90 min 3.96 ± 0.61 4.04 ± 0.19 
120 min 3.96 ± 0.61 4.04 ± 0.19 
180 min 4.28 ± 0.53 4.52 ± 0.51* 
240 min 4.48 ± 0.65 5.34 ± 1.00* 
300 min 4.68 ± 0.74 5.54 ± 0.73* 
360 min 4.52 ± 0.58 5.00 ± 0.49* 
Data expressed as mean ± (SD); *P value < 0.05. 
 
A number of patients who needed rescue 
analgesia (ketoprofen 1 mg/kg I.M.) were recorded. 
None of the patients required analgesia in the first two 
hours (as pain score was < 5) postoperatively in both 
groups.  
 
Figure 1: FLACC pain scale 6 hours postoperative 
 
There was a significant difference concerning 
the analgesic need between the two groups being 
lower in ‘A’ group compared to ‘B’ group which was 
statistically significant in 2-4 hours after surgery 
(group A 8% of cases while group B 32% of cases 
producing p-value < 0.05) and statistically insignificant 
in 4-6 hours after end of the surgery, however lower 
number of cases in group A compared to B (12% and 
18% of cases respectively) producing p-value > 0.05 
(Table 6).  
Ramsay sedation score was significantly 
higher in group ‘B’ when compared to group ‘A’ at 0 
and 30 minutes after recovery. But both groups have 
the same score (which is 2) from 30 minutes to 6 
hours postoperatively (Table 7). 
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Table 6: Need for rescue analgesia (Ketoprofen) at 6 hours 
postoperative 
  Group A Group B 
1
st 
2 hours 
postoperatively 
Count 0/50 0/50 
% within gruop 0% 0% 
2
nd
 2 hours 
postoperatively 
Count 4/50 16/50* 
% within gruop 8% 32%* 
3
rd
 2 hours 
postoperatively 
Count 6/50 9/50 
% within gruop 12% 18% 
Total Count 10/50 25/50* 
% within gruop 20% 50%* 
* P value < 0.05. 
 
The incidence of vomiting was monitored after 
surgery and was statistically different and significant 
between both groups being high in ‘B’ group 
compared to ‘A’ group which required intervention 
(Table 8).  
Table 7: Ramsay sedation score  
 Group A Group B 
15 min 1 ± 0 2.08 ± 0.9* 
30 min 1 ± 0 2.56 ± 0.541* 
30-360 min 2 ± 0 2±0 
* P value < 0.05. 
 
Although 6% of cases (3 cases out of 50) in 
group B developed respiratory depression "which was 
statistically insignificant as p-value <0.05", it is 
clinically significant and vitally important required 
immediate intervention (Table 9). 
Table 8: Incidence of vomiting  
 Group A Group B 
Vomiting Count 2/50 8/50* 
% within gruop 4% 16%* 
* P value < 0.05. 
 
There was no serious postoperative 
complication detected in either group.  
Table 9: Respiratory depression  
 Group A Group B 
Respiratory 
depression 
Count 0/50 3/50 
% within gruop 0% 6% 
P value > 0.05. 
 
 
 
Discussion 
 
Many studies were concerned with the post-
tonsillectomy pain management. These studies 
studied different routes, drugs and mechanisms for 
that pain management, e.g. I.V, I.M, rectal, local 
infiltration, etc. [16]. In this study, we found that 
patients had less pain in ‘group A’ with FLACC pain 
score (ranging from 3.18 ± 0.87 to 4.68 ± 0.741) 
compared to ‘group B’ with FLACC pain score 
(ranging from 3.90 ± 0.763 to 5.54 ± 0.734) six hours 
postoperatively and rescue analgesia was needed in 
less number of patients at 2-4 and 4-6 hours in ‘group 
A’ (20%) compared to ‘group B’ (50%) which was 
statistically significant. So intravenous ketorolac 
‘group A’ reduces pain intensity and postoperative 
analgesic requirements compared to nalbuphine 
‘group B’ group after adenotonsillectomy in children. 
In consistency with this study, Forrest et al. 
reported that ketorolac was more advantageous 
compared to opioid analgesics in the control of post-
tonsillectomy pain. This was due to lower rates of 
sedation, nausea, vomiting, and respiratory 
depression and a similar level of analgesia when 
using ketorolac, compared to commonly used opioids 
[17]. In agreement of the study, Tarkkila and 
Saarnivaara compared ketorolac, ketoprofen, and 
diclofenac postoperatively following elective 
tonsillectomy, and reported lower use of opioids, 
improved pain control, and a similar complication rate 
compared to placebo. These findings are similar to 
those we found in our trial [18].
 
According to Carney et 
al., ketorolac reduced the use of opioids and lowered 
the morbidity during the first 48 hours after pediatric 
surgery. Furthermore, patients receiving ketorolac did 
not present increased bleeding or kidney toxicity 
compared to the group that received morphine only. 
Shende and Das reported a lower rate of vomiting and 
pain when using ketorolac postoperatively after 
strabismus surgery in children compared to the 
placebo group [19], [20]. 
In this study, we found that patients in ‘group 
B’ were significantly more sedated compared to 
patients in ‘group A’ using the Ramsay sedation score 
at 15 and 30 minutes after recovery. Sedation score 
was (2.08 ± 0.9 at 15 min. and 2.56 ± 0.541 at 30 
min.) in ‘group B’ and was (1 ± 0 at 15 & 30 min.) in 
‘group A’ which was statistically significant. Sedation 
score was the same in the remaining observational 
hours after recovery in both groups and was 
statistically insignificant. So nalbuphine produces 
more sedation and less agitation during the early 
postoperative period which not preferred in ENT 
operations in general and pediatric surgeries in 
specific. 
In this study, we found that the incidence of 
postoperative vomiting was significantly higher in 
‘group B’ (16%) compared to that of ‘group A’ (4%). 
This is explained as opioids alter lower oesophagal 
sphincter activity, resulting in sphincter relaxation. 
Gastric emptying is delayed by opioids via supraspinal 
(vagus nerve-mediated), spinal and peripheral 
mechanisms [21].
 
Also, the study revealed that 
incidence of postoperative respiratory depression 
occurred in ‘group B’ (6%) compared to that of ‘group 
A’ in which no patient developed respiratory 
depression (0% ) which was statistically insignificant 
but clinically vital as it required immediate intervention 
[22].
 
In agreement with that Hamza et al., 2012
 
who compared the efficacy of ketorolac and pethidine 
for postoperative pain relief in the first 24 hours after 
tonsillectomy? One hundred patients age 5-12 years 
under going tonsillectomy were divided into group A 
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and B randomly, who received either inj. ketorolac 0.5 
mg/kg or inj. Pethidine 1 mg/kg I.M respectively 
postoperatively on 6 hourly bases. Patients were 
assessed in the recovery room and ENT ward for pain 
according to faces pain scale and for any side effects. 
Amount of rescue analgesia required by both groups 
was also recorded. They concluded that ketorolac 
provides similar analgesic effects as pethidine in the 
doses mentioned above with much less incidence of 
nausea, vomiting and drowsiness in the first 24 hours 
after adenotonsillectomy [23]. 
Limitation to the study was that patients were 
not followed up more than six “6” hours, as adequate 
acute pain management should be controlled and 
followed up in the first three “3” months as regarding 
the definition of acute pain of IASP “International 
Association for the Study of Pain” for better health 
care service and reducing a lot of morbidities which is 
an important issue for future studies. This was 
because tonsillectomy was performed on an 
ambulatory basis and most of the patients came from 
rural areas, where it would have been very difficult to 
track them after they had left the hospital. 
It was concluded that intravenous ketorolac is 
effective in reducing pain intensity and postoperative 
analgesic requirements after adenotonsillectomy in 
children. Also, it is generally safe as absent 
respiratory depression and a very low incidence of 
postoperative complications. It is recommended that 
the use of multimodal analgesia is the best way for 
acute postoperative pain management after 
adenotonsillectomy surgery. 
 
 
References 
 
1. Owezarzak V, Haddad J. Comparison of oral versus rectal 
administration of acetaminophen with codeine in postoperative 
pediatric adenotonsillectomy patients. Laryngoscope. 2006, 
116:1485-88. https://doi.org/10.1097/01.mlg.0000227530.64179.1f 
PMid:16885758  
2. Pickering AE, Dridge HS, Nolan J, Stoddart PA. Double-blind 
placebo-controlled study of ibuprofen or rofecoxib in combination 
with paracetamol for tonsillectomy in children. Br J Anaesth. 2002; 
88:72-77. https://doi.org/10.1093/bja/88.1.72 PMid:11881888  
 
3. Lee WC, Sharp JF. Complications of pediatric tonsillectomy 
postdischarge.J Laryngol Otol. 1996; 110:136-140. 
https://doi.org/10.1017/S0022215100132979 PMid:8729496  
 
4. Mc Callum PL, MacRae FL, Sukerman S, MacRae E. 
Ambulatory adenotonsillectomy in children less than 5 years of 
age. J Otolaryngol. 2001; 30:75-78. 
https://doi.org/10.2310/7070.2001.19826 
 
5. Kokki H, Ahonen R. Pain and activity disturbance after pediatric 
day care adenotonsillectomy. Pediatr Anest. 1997; 7:227-31. 
https://doi.org/10.1046/j.1460-9592.1997.d01-76.x PMid:9189969  
 
6. Carr DB, Jacox AK, Chapman CR, Ferrell B, Fields HL, Heidrich 
G. Clinical practice guidelines for acute pain management: 
operative or medical procedures and trauma. Washington, DC: 
Agency for Health Care Policy and Research. 1992:95-0034. 
 
7. Rusy LM, Houck CS, Sullivan LJ, Ohlms CB, et al. A double 
 
blind evaluation of ketorolac tromethamine versus acetaminophen 
in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg. 
1995; 80:226-9. PMid:7818104  
8. Hiller A, Silvanto M, Savolainen S, Tarkkila P. Propacetamol and 
diclofenac alone and in combination for analgesia after elective 
tonsillectomy. Acta Anaesthesiology Scand; 2004, 48:1185-89. 
https://doi.org/10.1111/j.1399-6576.2004.00473.x PMid:15352967  
 
9. Zacny JP, Conley K, Marks S. Comparing the subjective, 
psychomotor and physiological effects of intravenous nalbuphine 
and morphine in healthy volunteers. Journal of Pharmacology and 
Experimental Therapeutics. 1997; 280(3):1159-69. PMid:9067299  
 
10. Issioui T, Klein KW, White PF, Watcha MF, et al. The efficacy 
of premedication with celecoxib and acetaminophen in preventing 
pain after otolaryngologic surgery. Anesth Analg. 2002; 94:1188-
93. https://doi.org/10.1097/00000539-200205000-00025 
PMid:11973187  
 
11. Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, 
Feldman H et al. Parenteral ketorolac and risk of gastrointestinal 
and operative site bleeding. A postmarketing surveillance study. 
JAMA. 1996; 275(5):376- 82. 
https://doi.org/10.1001/jama.1996.03530290046036 PMid:8569017  
 
12. Carney DE, Nicolette LA, Ratner MH, Minerd A, Baesl T. 
Ketorolac reduces postoperative narcotic requirements. J Ped 
Surg. 2001; 36(1):76- 9. https://doi.org/10.1053/jpsu.2001.20011 
PMid:11150441  
 
13. Dsida RM, Wheeler M, Birmingham PK, Wang Z, Heffner CL, 
Coté CJ, Avram MJ. Age-stratified phermacokinetics of ketorolac 
tromethamine in pediatric surgical patients. Anesth Analg. 2002; 
94:266-70. https://doi.org/10.1213/00000539-200202000-00007 
PMid:11812682  
 
14. Merkel S, et al. The FLACC: A behavioral scale for scoring 
postoperative pain in young children. Pediatr Nurse. 1997; 23:293–
97. PMid:9220806  
 
15. Ramsay MAE, Savege TM, Simpson BRJ, and Goodwin 
R.Controlled sedation with alpaxalone-alphadolone. British Medical 
Journal. 1974; 2:656–659. https://doi.org/10.1136/bmj.2.5920.656 
PMid:4835444 PMCid:PMC1613102 
 
16. Alhashemi JA, Daghistani MF. Effects of intraoperative i.v. 
acetaminophen vs i.m. meperidine on post-tonsillectomy pain in 
children. Br J Anaesth. 2006; 96:790-5. 
https://doi.org/10.1093/bja/ael084 PMid:16613928  
 
17. Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative 
pain management in children. Drug Safety. 1997; 16(5):309-29. 
https://doi.org/10.2165/00002018-199716050-00003 
PMid:9187531  
 
18. Tarkkila P, Saarnivaara L. Ketoprofen, doclofenac or ketorolac 
for pain after tonsillectomy in adults? Br J Anaesth. 1999; 82(1):56-
60. https://doi.org/10.1093/bja/82.1.56 PMid:10325837  
 
19. Carney DE, Nicolette LA, Ratner MH, Minerd A, Baesl T. 
Ketorolac reduces postoperative narcotic requirements. J Ped 
Surg. 2001; 36(1):76-9. https://doi.org/10.1053/jpsu.2001.20011 
PMid:11150441  
 
20. Shende D, Das K. Comparative effects of intravenous ketorolac 
and pethidine on perioperative analgesia and postoperative nausea 
and vomiting (PONV) for paediatric strabismus surgery. Acta 
Anaesthesiol Scand. 1999; 43:265-9. 
https://doi.org/10.1034/j.1399-6576.1999.430305.x PMid:10081531  
 
21. Schurizek BA, Willacy LH, Kraglund K. Antroduodenal motility, 
pH and gastric emptying during balanced anaesthesia: Comparison 
of pethidine and fentanyl. Br J Anaesth. 1989; 62:674–82. 
https://doi.org/10.1093/bja/62.6.674 PMid:2751923  
 
22. Tarkkila P, Tuominen M, Lindgren L. Comparison of respiratory 
effects of tramadol and pethidine. Eur J Anaesthesiol. 1998; 15:64-
8. https://doi.org/10.1097/00003643-199801000-00013 
PMid:9522144  
 
23. AMIR H, UMER H, QAISER K, MUHAMMAD K. Compare the 
Efficacy of Ketorolac and Pethidine for Postoperative Pain Relief in 
First 24 Hours after Tonsillectomy. PJMHS. 2012; 6:326-328. 
 
 
